Aroa Biosurgery Limited (ARX.AX)
AUD 0.7
(2.96%)
AUD 0.7
(2.96%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.83 Million | -3.53 Million | -10.86 Million | -4.67 Million | 1.57 Million | -6535.24 |
| Net Income | -9.85 Million | -360.81 Thousand | -7.9 Million | -17.93 Million | -5.66 Million | 896.26 Thousand |
| Depreciation & Amortization | 4.08 Million | 3.5 Million | 2.95 Million | 2.87 Million | 2.6 Million | 1.92 Million |
| Deferred income taxes | - | - | - | - | - | -4 Million |
| Stock-based compensation | 2.91 Million | 2.41 Million | 2.74 Million | 1.84 Million | 404.7 Thousand | -6.23 Million |
| Change in working capital | -6.21 Million | -9.03 Million | -10.02 Million | -531.32 Thousand | -1.06 Million | -2.46 Million |
| Other non-cash items | 15.44 Million | 2.35 Million | 4.11 Million | 10.91 Million | 11.94 Million | 9.87 Million |
| Investing Cash Flow | 9.4 Million | 6.79 Million | -32.41 Million | -19.73 Million | -1.77 Million | -3.45 Million |
| Investments in PPE | -6.47 Million | -7.12 Million | -4.52 Million | -1.37 Million | -1.77 Million | -1.52 Million |
| Acquisitions | - | - | - | - | - | -1.92 Million |
| Investment purchases | - | - | -27.88 Million | -18.36 Million | - | - |
| Sales/Maturities of investments | 15.88 Million | 13.91 Million | - | - | - | - |
| Other Investing Activities | 12.54 Million | 0.26 | - | -18.6 Million | -173.3 Thousand | - |
| Financing Cash Flow | -958.47 Thousand | -471.77 Thousand | 34.97 Million | 34.05 Million | -364.86 Thousand | 3.86 Million |
| Debt repayment | -678.74 Thousand | -603.44 Thousand | -8.84 Million | -11.56 Million | -1.68 Million | -321.16 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -1.12 Million | -958.53 Thousand | -2.05 Million | -3.97 Million | - | - |
| Common Stock Issuance | 181.68 Thousand | 486.75 Thousand | 46.77 Million | 32.08 Million | 281.25 Thousand | 8.27 Million |
| Other Financing Activities | -269.66 Thousand | 0.66 | -895.06 Thousand | 35.68 Million | -1.81 Million | -4.73 Million |
| Accounts receivables | 811.09 Thousand | -2.38 Million | -9.79 Million | -71.9 Thousand | -1.93 Million | -2.23 Million |
| Accounts payables | 101.03 Thousand | 1.68 Million | 1.24 Million | -278.26 Thousand | 2.15 Million | 681.53 Thousand |
| Inventory | -3.03 Million | -2.5 Million | -304.45 Thousand | 590.15 Thousand | -1.26 Million | -829.97 Thousand |
| Other working capital | -4.09 Million | -5.81 Million | -1.17 Million | -771.3 Thousand | -24.7 Thousand | -77.48 Thousand |
| Cash at beginning of period | 8.91 Million | 5.77 Million | 14.29 Million | 3.53 Million | 4.27 Million | 3.64 Million |
| Cash at end of period | 10.56 Million | 8.93 Million | 5.73 Million | 14.12 Million | 3.72 Million | 4.27 Million |
| Capital Expenditure | -6.47 Million | -7.12 Million | -4.52 Million | -1.37 Million | -1.77 Million | -1.52 Million |
| Effect of forex changes on cash | 221.99 Thousand | 370.68 Thousand | -423.83 Thousand | 862.02 Thousand | -12.58 Thousand | 237 Thousand |
| Net cash flow / Change in cash | 1.65 Million | 3.15 Million | -8.56 Million | 10.58 Million | -549.89 Thousand | 631.91 Thousand |
| Free Cash Flow | -13.31 Million | -10.65 Million | -15.38 Million | -6.05 Million | -199.53 Thousand | -1.53 Million |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.98 Million | -9.85 Million | -2 Million | -5.83 Million | -2.9 Million | -360.81 Thousand |
| Depreciation & Amortization | 1.03 Million | 4.08 Million | 1.04 Million | 1.97 Million | 985.6 Thousand | 3.5 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 1.05 Million | 2.91 Million | 1.06 Million | 414.93 Thousand | 410.09 Thousand | 2.41 Million |
| Change in working capital | -3.11 Million | -6.21 Million | -3.14 Million | - | - | -9.03 Million |
| Other non-cash items | 2.97 Million | 15.44 Million | 3.01 Million | 1.05 Million | -1.85 Million | 2.35 Million |
| Investing Cash Flow | 3.76 Million | 9.4 Million | 3.8 Million | 1.79 Million | 892.52 Thousand | 6.79 Million |
| Investments in PPE | -647.56 Thousand | -6.47 Million | -654.68 Thousand | -2.95 Million | -972.7 Thousand | -7.12 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | 11.17 Million | 15.88 Million | - | 4.74 Million | - | 13.91 Million |
| Other Investing Activities | 4.41 Million | 12.54 Million | 4.46 Million | 1.88 Million | 1.86 Million | 0.26 |
| Financing Cash Flow | -219.21 Thousand | -958.47 Thousand | -221.62 Thousand | -514.06 Thousand | -256.19 Thousand | -471.77 Thousand |
| Debt repayment | - | -678.74 Thousand | - | - | - | -603.44 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -1.12 Million | - | - | - | -958.53 Thousand |
| Common Stock Issuance | 128.53 Thousand | 181.68 Thousand | - | 53.62 Thousand | - | 486.75 Thousand |
| Other Financing Activities | -219.21 Thousand | -269.66 Thousand | -221.62 Thousand | -259.22 Thousand | -256.19 Thousand | 0.66 |
| Accounts receivables | 413.2 Thousand | 811.09 Thousand | 417.75 Thousand | - | - | -2.38 Million |
| Accounts payables | - | 101.03 Thousand | - | - | - | 1.68 Million |
| Inventory | -1.5 Million | -3.03 Million | -1.51 Million | - | - | -2.5 Million |
| Other working capital | -2.02 Million | -4.09 Million | -2.04 Million | - | - | -5.81 Million |
| Cash at beginning of period | 3.68 Million | 8.91 Million | -0.08 | 8.91 Million | - | 5.77 Million |
| Cash at end of period | 10.56 Million | 10.56 Million | 3.5 Million | 3.68 Million | -2.57 Million | 8.93 Million |
| Capital Expenditure | -647.56 Thousand | -6.47 Million | -654.68 Thousand | -2.95 Million | -972.7 Thousand | -7.12 Million |
| Effect of forex changes on cash | -42.65 Thousand | 221.99 Thousand | -43.12 Thousand | 156.18 Thousand | 154.36 Thousand | 370.68 Thousand |
| Net cash flow / Change in cash | 6.88 Million | 1.65 Million | 3.5 Million | -5.22 Million | -2.57 Million | 3.15 Million |
| Free Cash Flow | -681.49 Thousand | -13.31 Million | -688.99 Thousand | -9.7 Million | -4.33 Million | -10.65 Million |
NVDA
OZYSR
LIN
EPIAF
MDI
1073